MU
79
3
MSI
47
-2
TSN
47
3
PM
56
2
SJM
14
3
VTR
70
3
UA
38
3
FTI
61
-2
F
58
2
NVDA
57
-2
SLG
37
6
KMB
33
2
DLTR
58
3
ETN
61
2
CNP
55
3
DUK
59
4
GT
39
2
NEM
69
-2
CPB
37
2
ZBH
45
3
MU
79
3
MSI
47
-2
TSN
47
3
PM
56
2
SJM
14
3
VTR
70
3
UA
38
3
FTI
61
-2
F
58
2
NVDA
57
-2
SLG
37
6
KMB
33
2
DLTR
58
3
ETN
61
2
CNP
55
3
DUK
59
4
GT
39
2
NEM
69
-2
CPB
37
2
ZBH
45
3
Financhill
Back

Dave, Inc. Vs. Alnylam Pharmaceuticals, Inc. Industry Stock Comparison

Buy
73

DAVE
Dave, Inc.

Last Price:
$228.86
Seasonality Move:
78.89%
Sell
45

ALNY
Alnylam Pharmaceuticals, Inc.

Last Price:
$400.79
Seasonality Move:
0.84%
Buy
73
Dave, Inc. (DAVE) is a Buy

Is Dave, Inc. a Buy, Sell or Hold?

  • The current Dave, Inc. [DAVE] share price is $228.69. The Score for DAVE is 73, which is 46% above its historic median score of 50, and infers lower risk than normal.
  • DAVE is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
45
Alnylam Pharmaceuticals, Inc. (ALNY) is a Sell

Is Alnylam Pharmaceuticals, Inc. a Buy, Sell or Hold?

  • The current Alnylam Pharmaceuticals, Inc. [ALNY] share price is $400.69. The Score for ALNY is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
  • ALNY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

DAVE Stock Price Chart

What is Dave, Inc.'s stock price today?

  • The Dave, Inc. share price today is $228.69
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DAVE is experiencing buying pressure, which is a positive indicator for future bullish movement.

ALNY Stock Price Chart

What is Alnylam Pharmaceuticals, Inc.'s stock price today?

  • The Alnylam Pharmaceuticals, Inc. share price today is $400.69
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ALNY is experiencing buying pressure, which is a positive indicator for future bullish movement.

DAVE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.52 Buy
Relative Strength Index (14 RSI): 61.33 Buy
Chaikin Money Flow: 121723 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (194.04 - 215.12) Buy
Bollinger Bands (100): (194.75 - 229.65) Buy

ALNY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -13.98 Sell
Relative Strength Index (14 RSI): 38.99 Sell
Chaikin Money Flow: 309036 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (399.2 - 453.4) Sell
Bollinger Bands (100): (425.75 - 469.75) Sell

DAVE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 209.83 Buy
20-day SMA: 206.66 Buy
50-day SMA: 216.61 Buy
200-day SMA: 188.45 Buy
8-day EMA: 214.33 Buy
20-day EMA: 209.61 Buy
50-day EMA: 211.5 Buy
200-day EMA: 185.59 Buy

ALNY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 397.27 Buy
20-day SMA: 422.53 Sell
50-day SMA: 442.75 Sell
200-day SMA: 368.05 Buy
8-day EMA: 402.46 Sell
20-day EMA: 415.69 Sell
50-day EMA: 431.03 Sell
200-day EMA: 383.3 Buy

Dave, Inc. Earnings Growth & DAVE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $1.40 per share, a decrease next quarter of $0.00 per share, an increase this year of $9.18 per share, and an increase next year of $0.09 per share.

Alnylam Pharmaceuticals, Inc. Earnings Growth & ALNY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $1.34 per share, a decrease next quarter of $0.00 per share, an increase this year of $5.20 per share, and an increase next year of $6.23 per share.

Dave, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Alnylam Pharmaceuticals, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):